![AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity: Molecular Therapy - Nucleic Acids AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/dbe9ae6d-8779-431b-b5fb-7c56fc63eac8/fx1.jpg)
AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity: Molecular Therapy - Nucleic Acids
![The workflow for functional siRNA prediction with a new design algorithm. | Download Scientific Diagram The workflow for functional siRNA prediction with a new design algorithm. | Download Scientific Diagram](https://www.researchgate.net/publication/38027476/figure/fig1/AS:214057408831494@1428046671755/The-workflow-for-functional-siRNA-prediction-with-a-new-design-algorithm.png)
The workflow for functional siRNA prediction with a new design algorithm. | Download Scientific Diagram
![Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates: Molecular Therapy Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates: Molecular Therapy](https://www.cell.com/cms/attachment/fcc674c9-1a93-421f-bcb6-ab53bdf3687c/gr1_lrg.jpg)
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates: Molecular Therapy
![A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/ca908dae-790a-4b91-a3b8-087756edbf99/gr1.jpg)
A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids
![siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c06455/asset/images/large/ao1c06455_0008.jpeg)
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
![Ambion™ Silencer™ Pre-Designed siRNA, In Vivo: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific Ambion™ Silencer™ Pre-Designed siRNA, In Vivo: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
Ambion™ Silencer™ Pre-Designed siRNA, In Vivo: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific
![Pharmaceutics | Free Full-Text | Analyzing siRNA Concentration, Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse Transcription-qPCR Pharmaceutics | Free Full-Text | Analyzing siRNA Concentration, Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse Transcription-qPCR](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01348/article_deploy/html/images/pharmaceutics-14-01348-g001.png)
Pharmaceutics | Free Full-Text | Analyzing siRNA Concentration, Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse Transcription-qPCR
![Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms8930/MediaObjects/41467_2015_Article_BFncomms8930_Fig1_HTML.jpg)
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications
![siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c06455/asset/images/medium/ao1c06455_0009.gif)
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
![Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00575/article_deploy/html/images/pharmaceuticals-15-00575-g001.png)
Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
![Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing: Molecular Therapy - Nucleic Acids Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/fe927af4-cbc5-4c12-89e6-a9191c668d8e/fx1.jpg)
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing: Molecular Therapy - Nucleic Acids
![IJMS | Free Full-Text | Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID IJMS | Free Full-Text | Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID](https://www.mdpi.com/ijms/ijms-21-05218/article_deploy/html/images/ijms-21-05218-g001.png)
IJMS | Free Full-Text | Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
![Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/0dca4bd6-cb0a-454b-82ee-3b5168b6fde7/fx1.jpg)